JSNM2024/JSNMT2024

Presentation information

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 22:RI Therapy・Thyroid, MIBG, Radium Chloride

Fri. Nov 8, 2024 8:50 AM - 9:50 AM Room 2 (5F 503, Conference Center, PACIFICO Yokohama)

座長:阿部 光一郎(東京医科大学)、三宅 可奈江(京都大学大学院医学研究科 高度医用画像学講座)

[2-MO22-4] Relationship between thyroid absorbed dose and treatment outcome in I-131 treatment

Yusuke Iizuka1,2、Takuya Kosaka2、Takahiro Kishi2、Mizuki Osada3、Yuki Yamaguchi3、Atsushi Miura3、Akira Otomaru3 (1.Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan、2.Department of radiation oncology, Shizuoka City Shizuoka Hospital, Shiauoka, Japan、3.Department of Radiation-technology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan)

Abstract password authentication.

The password is listed on page 9 of the Program Book.

Password